Skip to main content
. 2021 Feb 1;76:e2355. doi: 10.6061/clinics/2021/e2355

Table 2. Comparison of treatment efficacy between the two groups (n (%)).

Group Cure Improvement Invalid Total effective rate
Control group (n=51) 16 (31.37) 23 (45.10) 12 (23.53) 39 (76.47)
Study group (n=51) 21 (41.18) 26 (50.98) 4 (7.84) 47 (92.16)
χ2 4.744
p 0.029